Keith Goldan

Keith Goldan

Director of Finance/CFO presso SYNDAX PHARMACEUTICALS, INC.

Patrimonio netto: 1 M $ in data 31/03/2024

52 anni
Health Technology
Consumer Services
Retail Trade

Profilo

Keith Alan Goldan is the founder of Century Capital Associates.
He is currently the Treasurer, Chief Financial & Accounting Officer at Syndax Pharmaceuticals, Inc. (since 2023).
Previously, he held the position of Chief Financial Officer & Director at Realm Therapeutics Plc (2004-2008), CFO, Treasurer & Senior Vice President at Fibrocell Science, Inc. (2015-2017), Chief Financial Officer & Senior Vice President at NuPathe, Inc. (2013-2014), and Chief Financial Officer at OptiNose, Inc. (2017-2022).
He also served as the Chief Financial Officer & Vice President at Biosyn, Inc. and Chief Financial Officer at Cantel Medical (UK) Ltd.
Mr. Goldan obtained an undergraduate degree from the Robert H.
Smith School of Business and an MBA from The Wharton School of the University of Pennsylvania.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
08/03/2024 51 373 ( 0.06% ) 1 M $ 31/03/2024

Posizioni attive di Keith Goldan

SocietàPosizioneInizio
SYNDAX PHARMACEUTICALS, INC. Director of Finance/CFO 13/06/2022
Tutte le posizioni attive di Keith Goldan

Precedenti posizioni note di Keith Goldan

SocietàPosizioneFine
OPTINOSE, INC. Director of Finance/CFO 10/06/2022
FIBROCELL SCIENCE, INC. Director of Finance/CFO 01/01/2017
NUPATHE INC Director of Finance/CFO 21/02/2014
Director of Finance/CFO 31/10/2008
REALM THERAPEUTICS PLC Director of Finance/CFO 13/10/2008
Vedi nel dettaglio l'esperienza di Keith Goldan

Formazione di Keith Goldan

Robert H. Smith School of Business Undergraduate Degree
The Wharton School of the University of Pennsylvania Masters Business Admin

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Keith Goldan

Relazioni

82

Relazioni di 1° grado

10

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa2
SYNDAX PHARMACEUTICALS, INC.

Health Technology

OPTINOSE, INC.

Health Technology

Aziende private6

Health Technology

Health Technology

Health Technology

Health Technology

Retail Trade

Century Capital Associates

Vedi le connessioni aziendali